Page 8 - Inaugural HKU Urology Congress program book (high resolution) 2026 0723
P. 8

INTERNATIONAL                                                                                                          INTERNATIONAL


                                            FACULTY                                                                                                                FACULTY



                                            BIOGRAPHY                                                                                                              BIOGRAPHY










                                            Woon-Chau Tsang                                                                                                        Hai-Feng Wang




                   Dr. Woon-Chau Tsang is a Consultant Urologist at the National University Hospital (NUH),                               Professor Hai-Feng Wang is currently the Director of the Department of Urology at

                   Singapore, with a clinical and academic focus on prostate cancer diagnostics and MRI                                   Shanghai Eastern Hospital, affiliated with Tongji University, where he also serves as Full
                   fusion-guided prostate biopsy. He graduated from Queen’s University of Belfast, United                                 Professor.
                   Kingdom, and previously practiced in the UK at the John Radcliffe Hospital NHS Trust and

                   The Churchill Hospital, Oxford, before joining NUH in 2010.                                                            Professor Wang is a highly experienced urologist with a strong clinical and academic
                                                                                                                                          focus on prostate cancer, particularly in advanced diagnostic and minimally invasive

                   Dr. Tsang has extensive experience with the Mona Lisa robotic MRI-US fusion biopsy                                     treatment strategies. Over the past decade, his work has centred on robot-assisted radical
                   platform, having performed more than 1,400 Mona Lisa cases since adopting the                                          prostatectomy, MRI-targeted prostate biopsy, and focal therapies, including pioneering
                   technology in September 2015. He has been actively involved in advancing transperineal                                 applications of high-frequency irreversible electroporation (H-FIRE).

                   robotic prostate biopsy practices in the region.  Academically, Dr. Tsang has authored
                   26 journal articles and 23 conference papers, with key contributions in prostate biopsy                                Professor Wang has led and contributed to numerous important clinical studies, including

                   and prostate cancer diagnostics. He has also served as faculty and presenter at major                                  multicentre trials evaluating the efficacy and safety of irreversible electroporation in
                   international urology congresses, with several presentations at the European Association                               localized prostate cancer, with his research published in leading journals such as JAMA
                   of Urology (EAU) Congress and at the American Urological Association (AUA) meetings.                                   Surgery, European Urology and eClinicalMedicine.



                   Dr. Tsang continues to contribute actively to clinical research, education, and innovation in                          Professor Wang has authored more than 20 peer-reviewed publications and is widely
                   precision prostate cancer diagnostics as part of the multidisciplinary prostate cancer care                            recognised for his contributions to advancing image-guided biopsy techniques, focal

                   team at the National University Cancer Institute, Singapore (NCIS).                                                    therapy, and translational research in urologic oncology.






















                                                            6                                                                                                                      7
   3   4   5   6   7   8   9   10   11   12   13